MN SF131 | 2021-2022 | 92nd Legislature

Status

Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on January 14 2021 - 25% progression
Action: 2021-01-14 - Referred to Health and Human Services Finance and Policy
Pending: Senate Health and Human Services Finance and Policy Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Drug manufacturers requirement to report and maintain prescription drug prices authorization; prescription drug formularies filing requirement; health carriers denying or limiting coverage due to lack of prior authorization prohibition; prescription benefit tool requirements establishment; prescription drug benefit transparency and disclosure requirement

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Drug manufacturers requirement to report and maintain prescription drug prices authorization; prescription drug formularies filing requirement; health carriers denying or limiting coverage due to lack of prior authorization prohibition; prescription benefit tool requirements establishment; prescription drug benefit transparency and disclosure requirement

Sponsors


History

DateChamberAction
2021-01-14SenateReferred to Health and Human Services Finance and Policy
2021-01-14SenateIntroduction and first reading

Same As/Similar To

HF58 (Similar To) 2021-01-19 - Authors added Schultz, Reyer, and Bahner

Minnesota State Sources


Bill Comments

feedback